Terumo, a global leader in medical technology, celebrates its centenary in 
Asia. From humble beginnings as a thermometer manufacturer in 1921, and the 
first company in 1963 to create disposable syringes in Japan, the company has 
been providing medical solutions for the healthcare community and quality 
products to patients.

Terumo Asia Holdings(https://www.terumo.com/contact/locations/asia-pacific/) 
was established as a subsidiary of Terumo Corporation in 2012. The subsidiary 
oversees 14 Asia entities across 9 countries.

Forged, tested and ready for the next 100 years

During the pandemic, Terumo Asia Holdings was instrumental in supporting 
scale-up initiatives that government medical systems and the healthcare 
community required by bringing in COVID-19 centric therapies, setting up plasma 
therapy centres, building project sites, protocols, supporting disinfection 
activities, and initiating dialogue between physicians across Asia. 

Probir Das, Chairman and Managing Director, Terumo Asia Holdings said: "The 
pandemic was a test of our organisation's resilience that we passed with flying 
colours. We are honored to have talented employees globally, along with great 
channel and business partners, who work daily to serve our customers and 
advance our efforts in the healthcare industry. The Terumo mentality is to 
serve our customers and strengthen the community through innovating 
high-quality products."

As countries shift to an endemic strategy, Terumo will expand its impact 
through automation and digital integration with hospital information systems 
and enhance the delivery of healthcare.

Achieving forward momentum through our celebration in Asia

During its centennial year, Terumo Asia Holdings gave back to communities where 
Associates are based in. This included '100 hours of CSR', which encouraged 
Associates to give back through ways they are passionate about; and 'Plant A 
Tree', which helped beautify outdoor environments, and enhance green spaces.

With the theme of "Stride Ahead", Terumo Asia Holdings celebrated the 100th 
anniversary with 9 different activations over 7 months, which culminated in the 
achievement of a GUINNESS WORLD RECORDS Title.

In a first of its kind attempt, Terumo Asia Holdings achieved the title with 
over 500 people across Asia participating for 'the largest online video chain 
of people passing and using a thermometer'.

Mr Das said: "Achieving our first 100-year milestone is gratifying and proves 
that our mission is as true now as it was at the beginning. The Guinness World 
Records title achieved by our Associates and the thermometer is symbolic of our 
founding in 1921 while demonstrating social responsibility amidst the pandemic. 
With the celebrations, we reaffirm commitment to our mission and remain 
undaunted in support of the healthcare community."

Additional quotes: 

Akaike Toshiyuki, President, Terumo Philippines Corporation:

"This is a fantastic milestone to achieve. Our core values coupled with our 
culture of togetherness will see us achieve more as we aim for the next 100 
years!"

Florian Deichmann, General Director, Terumo Blood and Cell Technologies Vietnam 
Co. Ltd:

"Terumo's success is tied to our ability to meet the demands of different 
cultures and countries. We are excited about our future, and what we will do in 
the next 100 years!"

Takumi Uchida, General Director, Terumo Vietnam Co. Ltd

"Our common mission of contributing to society through healthcare has served us 
well as a north star. Our forward momentum continues to build with the 
provision of ideas, innovation and quality to the healthcare community."

About Terumo

Terumo is a global leader in medical technology and has been committed to 
"Contributing to Society through Healthcare" for 100 years. Based in Tokyo and 
operating globally, Terumo employs more than 25,000 associates worldwide to 
provide innovative medical solutions in more than 160 countries and regions. 
The company started as a Japanese thermometer manufacturer and has been 
supporting healthcare ever since. Now, its extensive business portfolio ranges 
from vascular intervention and cardio-surgical solutions, blood transfusion and 
cell therapy technology, to medical products essential for daily clinical 
practice such as transfusion systems, diabetes care, and peritoneal dialysis 
treatments. Terumo will further strive to be of value to patients, medical 
professionals, and society at large.

SOURCE:  Terumo Asia Holdings